Impact of Immunosenescence on Immune-Related Adverse Events in Elderly Patients With Cancer.

Aging Med (Milton) · 2025 · PMC11864504 · PMID 40012861

Europe PMC DOI

hedged sentence

0.3530

closest p · 7.1× alpha

0.3530

boldest claim

The sentences

did not reach statistical significancep = 0.353not close (p > 0.1)

The study revealed a higher incidence of grade 3–5 irAEs in patients aged ≥ 70 compared to those aged < 70, but it did not reach statistical significance (18.6% vs. 12.9%, p = 0.353) [ 3 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.